Wei-ping Wang and Fang Liu
Yi Xu, Wei-wei Fu, Shi Chen, Yue-fang Dong, Ke-ke Gu and Li-ping Wang
Yong-jie Wang, Yi-bo Wang, Dun-wei Du and Yan-ping Bai
Guang-Wei Zhang, Hu-Yuan Zhang, Jin-Fang Wang, Lang Zhou, Ping Liu and Xiao Jiang
The objective of this paper is to evaluate the self- healing properties of a commercially-available geosynthetic clay liner (GCL) using flexible-wall permeameter. The GCLs are produced by the same factory, but the contents of bentonite are different. Also the hydraulic conductivities (HC) of GCLs with no defect are different. In this study, specimens were completely saturated under the backpressure of 20 kPa before the test. Permeability tests were performed on GCL specimens with penetrating flaw and also on specimens permeated with distilled water and CaCl2 solutions. The test results were presented and discussed. Experimental results showed that the GCL with penetrating flaw did not exhibit complete self-healing in the case of flaw. After 120 days, the hydraulic conductivity increased by approximately an order of magnitude. In addition, CaCl2 solutions had a significant influence on the hydraulic conductivity. The research findings might be of interest to researchers and engineers who design liners for landfills and other liquid containment facilities
Hong Du, Jing Li, Hai-tao Yu, Wei Jiang, Ye Zhang, Jun-ning Wang, Ping-zhong Wang and Xue-fan Bai
Objective To observe the application of continuous renal replacement therapy (CRRT) and heparin anticoagulation in patients with HFRS, and to explore a more suitable anticoagulant strategy.
Methods Eighty-five severe-type patients (severe group) and 71 critical-type patients (critical group) were enrolled in this study. The frequency of CRRT was compared between the two groups; the frequency of CRRT treated with and without heparin anticoagulation and the frequency of hemorrhage and channel blood clotting induced by the two anticoagulant strategies were observed.
Results The frequency of CRRT in the critical group was higher than that in the severe group (P ＜ 0.001). The frequency of CRRT initiated during the overlapping phases in the critical group was significantly higher than that of the severe group (P = 0.032). The total times of CRRT was 103, and 70 of them were treated with heparin anticoagulation. The frequencies of hemorrhage induced by heparin anticoagulation and no heparinization were 16 and 0, respectively, and the frequencies of channel blood clotting were 2 and 4, respectively.
Conclusions CRRT has been used extensively in the critical-type patients with HFRS. The heparin anticoagulation and no anticoagulant strategies should be used more rationally in patients treated with CRRT, according to the clinical characteristics of the disease.
Wen Wang, Ci-You Huang, Zhuo-Ping Wang, Shan-Shan Xu, Tie-Yong Qian, Yi-Ding Chen and Wei-Guo Wu
Background: The chemokine C-C motif ligand 11, also known as eotaxin-1, has been identified as a novel mediator of inflammatory bone resorption. However, little is known regarding a potential role for CCL11/Eotaxin-1 in postmenopausal osteoporosis. Objective: The scope of this study was to explore the relationship between serum CCL11/Eotaxin-1 concen - trations and disease progression of postmenopausal females with osteoporosis. Methods: A total of 83 postmenopausal women diagnosed with osteoporosis were enrolled. Meanwhile, 82 post - menopausal women with normal bone mineral density (BMD) and 85 healthy controls inner child-bearing age were enrolled as control. The Dual-energy X-ray absorptio - metry was used to examine the BMDs at the femoral neck, lumbar spine 1-4 and total hip of all participants. Serum CCL11/Eotaxin-1 levels were examined by enzyme-linked immunosorbent assay. We also included inflammation marker interleukin-6 (IL-6) as well as a serum marker of bone resorption C-telopeptide cross-linked collagen type 1 (CTX-1). The Visual Analogue Scale (VAS) and Oswestry Disability Index (ODI) were recorded to evaluate the clinical severity in POMP females. Results: Serum CCL11/Eotaxin-1 levels were significantly elevated in postmenopausal osteoporotic patients PMOP patients compared with PMNOP and healthy controls. We observed a significant negative correlation of serum CCL11/Eotaxin-1 levels with lumbar spine, femoral neck and total hip BMD. Furthermore, serum CCL11/ Eotaxin-1 concentrations were also positively related to the VAS and ODI scores. Last, serum CCL11/ Eotaxin-1 concentrations were positively associated with IL-6 and CTX-1 levels. These correlations remain significant after adjusting for age and BMI. Multivariate linear regression analysis demonstrated that CCL11/Eotaxin-1 could serve as an independent marker. Conclusion: Serum CCL 11/Eotaxin-1 may serve as a candidate biomarker for postmenopausal osteoporosis. Therapeutics targeting CCL11/Eotaxin-1 and its related signalling way to prevent and slow progression of PMOP deserve further study.
Chun-ling Liu, Chun-wei Wang, Ying Liu, Ping Zhou, Xiao-juan Li, Hui-yuan Si and Hongwei Zhang
A twenty-eight-year-old male patient with five-day’s fever (the highest body tempreture reached 39.4°C) and 10-hour’s rash (first on face) presented to the department of emergency for “drug rash”, at that time his temperature was 38.6°C. Two hours later, his temperature fell to normal. Then this patient’s entire body rash increased significantly and lasted for 13 hours. Serum measles antibody IgM(+) confirmed the measles diagnosis. He had received measles vaccine as a baby. Clinicians should be aware of this atypical clinical manifestation of adult measles. If this kind of patients were misdiagnosed as drug rash and given corticosteroid, measles disease may be aggravated. Specific serum measles antibody testing may be the only reliable method for differential diagnosis, but the earliest time point for examining the antibodies of measles still needs precise research.
Chun-Ru Liu, Gong-Ming Yin, Hui-Ping Zhang, Wen-Jun Zheng, Pierre Voinchet, Fei Han, Duo Wang, Wei-Juan Song and Jean-Jacques Bahain
The Minjiang River terrace along the Longmen Shan fault zone near Wenchuan, at the eastern margin of the Tibetan Plateau, China, provides archives for tectonic activity and quaternary climate change. However, previous studies were not able to provide ages older than 100 ka due to the limitations of dating material or/and methods applied to date the fluvial sediments. In this study, we used the ESR signal of the Ti-Li center in quartz to obtain the ages of four higher terraces (T3–T6). According to the results, the terraces T3 to T6 were formed at 64±19 ka, 101±15 ka, 153±33 ka, and 423±115 ka, respectively. Combined with previous studies, these results indicate that the formations of all terraces correspond to glacial/interglacial transition periods, such as, T1-T5 being correlated to MIS2/1, MIS4/3, MIS5d/5c, and MIS6/5e respectively, while T6 probably to MIS12/11. According to these data, it is found that the average incision rate was significantly higher over the last 150 ka than that previous 100 ka (250 to 150 ka). As both tectonics and climate have affected the formation of these terraces, in addition to the overall uplifting of Tibetan Plateau, the regional uplift due to isostasy would be an additional tectonic factor in the formation of river terraces in the eastern margin of Tibetan plateau.
Chun-Ru Liu, Gong-Ming Yin, Fang Fang, Pierre Voinchet, Cheng-Long Deng, Fei Han, Jian-Ping Li, Wei-Juan Song, Duo Wang and Jean-Jacques Bahain
The fluvio-lacustrine sequences in the Nihewan Basin, northern China, provide important terrestrial archives about Palaeolithic settlements and, therefore, about early human occupation in high northern latitude in East Asia. Here we present detailed ESR dating of the Donggutuo Palaeolithic site, located in this basin. Four levels A, B, C and E of the Donggutuo archaeological layer yield ESR ages ranging from 1060±129 ka to 1171±132 ka with a mean of 1119±132 ka. The ages are consistent with the paleomagnetic data, which show that the Donggutuo Palaeolithic site lies just below the onset of the Jaramillo normal subchron (0.99–1.07 Ma). Furthermore, our results indicate that the reliable ESR dating range of bleached quartz using Ti-Li centre can be effectively extended to 1100 ka and the Ti-Li centre was zeroed before the last deposition, which requires improvement of the understanding of the bleaching mechanism conditions.
Wen Xie, Hong Zhao, Yu Chen, Qin Zhang, Wei Lu, Wei Liu, Ai-rong Hu, Han-wei Li, Ping Feng, Ming-sheng Chen, Cun-jin Mei, Xiao-lin Guo, Xiao-hu Zhao, Jiang-bin Wang, Zheng-qin Fan, Jian-he Gan, Qing Xie and Jun Cheng
Obejective Ademetionine 1,4-butanedisulfonate [S-adenosyl-L-methionine (SAMe)/Transmetil®, Abbott] has been available in China for more than 15 years, and it has been shown to reduce serum bilirubin and transaminase levels in viral hepatitis (VH) patients. However, no large-scale studies have focused on the impact of SAMe treatment regimen on reducing the serum total bilirubin (TBil) in VH patients with intrahepatic cholestasis (IHC). The primary purpose of this study was to evaluate the effectiveness of intravenous SAMe (Transmetil®) treatment in reducing the serum TBil by 50%.
Methods This retrospective, multi-center, cross-sectional medical record review involved patients aged ≥18 years. Records of 1 280 hospitalized VH patients at 16 sites diagnosed with IHC who had received intravenous SAMe 1 000 mg or 2 000 mg q.d. for at least 7 days from January 1, 2006 to June 30, 2009, were screened and 905 records were randomly selected.
Results The safety set (SS) included 834 patients and the full analysis set 826 patients. TBil levels after 14 days injection treatment were available for 763 patients. TBil decreased ≥ 50% versus baseline after 14 days treatment in 288 (37.7%) patients (95% CI 34.3%, 41.2%). Twenty-nine non-serious adverse events (non-SAEs) were reported in 19 (2.3%) patients, and 29 SAEs were reported in 10 patients (1.2%). All adverse events (AEs) were considered unrelated to the study drug.
Conclusions This retrospective study shows that intravenous SAMe administration in VH patients with IHC is associated with significant reduction of TBil levels in more than 30% of patients 14 days after treatment initiation.